| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/05/2008 | EP1653943B1 Catechol derivatives for the treatment of cancer |
| 03/05/2008 | EP1583504A4 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 03/05/2008 | EP1070253B1 USE OF hRORalpha RECEPTORS FOR SCREENING SUBSTANCES USEFUL FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 03/05/2008 | EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 03/05/2008 | CN101137390A Novel angiogensis inhibitor |
| 03/05/2008 | CN101137358A Antiviral compositions and methods of use |
| 03/05/2008 | CN101134109A Anticancer prior-medicine and method for preparing the same and use thereof |
| 03/05/2008 | CN101134038A 缓释的口服给药组合物 The sustained-release composition for oral administration |
| 03/05/2008 | CN101134032A Compound preparations for treating hypertension and method for preparing the same |
| 03/05/2008 | CN101134012A Method for producing injectable drug administration preparations using mixed polyacid anhydride as the carrier for middle-size or small molecule medicament and application thereof |
| 03/05/2008 | CN100372566C Targeted delivery of drugs for treatment of viral infections |
| 03/05/2008 | CN100372539C Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 03/04/2008 | US7340299 Methods of indirectly stimulating the vagus nerve to achieve controlled asystole |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339029 Sperm-specific cation channel, CatSper2, and uses therefor |
| 03/04/2008 | US7338970 Containing microcrystalline cellulose, lubricant, colloidal silica and lactose; use in treating depression, Parkinson's disease and severe psychotic disorders, such as schizophrenia and schizoaffective disorders. |
| 03/04/2008 | US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent |
| 03/04/2008 | US7338953 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 03/04/2008 | US7338946 Indazolium trans-[tetrachlorobis(1H-indazol)-ruthenate(III)]; easily water-soluble; exhibits a high effectiveness in the treatment of cancer illnesses |
| 02/28/2008 | WO2008024734A2 Use of pkc inhibitors in particular indolylmaleimide derivatives in ocular diseases |
| 02/28/2008 | WO2008024677A1 Biomarkers for alzheimer's disease progression |
| 02/28/2008 | WO2008024484A1 Methods and compositions for treating cancer |
| 02/28/2008 | WO2008024409A1 Progenitor cell replication and differentiation in 3d |
| 02/28/2008 | WO2008024374A2 Inhibitors of pancreatic phospholipase a2 for altering cholesterol and fat uptake |
| 02/28/2008 | WO2008024305A2 Bis (thiohydrazide amides) for treating melanoma |
| 02/28/2008 | WO2008023784A1 Agent for amelioration of ophthalmic circulatory disorder |
| 02/28/2008 | WO2008023725A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 02/28/2008 | WO2008023446A1 Remedy for chronic obstructive pulmonary disease |
| 02/28/2008 | WO2008023362A2 Use of a combination of methotrexate and an a3ar agonist for the treatment of cancer |
| 02/28/2008 | WO2008022484A2 Combinations of 5-ht3 receptor antagonists for topical treatment of disorders of skin |
| 02/28/2008 | WO2008022472A1 Pharmaceutical composition |
| 02/28/2008 | WO2008003013A3 Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |
| 02/28/2008 | WO2007146900A3 Antihypertensive therapy method |
| 02/28/2008 | WO2007137167A3 Co-therapy for the treatment of epilepsy |
| 02/28/2008 | WO2007128526A3 Combination comprising a vegf inhibitor and a serine protease for treating neovascular diseases |
| 02/28/2008 | WO2007087667A3 Combination preparation for improving sperm quality |
| 02/28/2008 | WO2007084670A8 Specific therapy using integrin ligands for treating cancer |
| 02/28/2008 | US20080051490 Medical Devices and Applications of Polyhydroxyalkanoate Polymers |
| 02/28/2008 | US20080051444 Compounds for the reduction of excessive food intake |
| 02/28/2008 | US20080051443 Compounds for the reduction of excessive food intake |
| 02/28/2008 | US20080051408 Use of a Pde 5 Inhibitor for Treating and Preventing Hypopigmentary Disorders |
| 02/28/2008 | US20080051403 Treatment For Alzheimer's Disease And Related Conditions |
| 02/28/2008 | US20080051378 Combinations Comprising Antimuscarinic Agents and Corticosteroids |
| 02/28/2008 | US20080051366 Aminosugar, glycosaminoglycan, and s-adenoslymethionine composition for the treatment and repair of connective tissue |
| 02/28/2008 | US20080051341 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080050751 Nonhuman model animal of th2-mediated hyperimmune response |
| 02/28/2008 | US20080050461 Nanoparticulate compositions of angiogenesis inhibitors |
| 02/28/2008 | US20080050453 Comprises selenium, copper, zinc, manganese and/or chromium, and EDTA |
| 02/28/2008 | US20080050427 Analgesic combination of tramadol and meloxicam |
| 02/28/2008 | US20080050421 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050420 Methods for reducing neovascularization or edema |
| 02/28/2008 | US20080050417 Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof |
| 02/28/2008 | US20080050389 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 02/28/2008 | US20080050373 Treatment with anti-erbb2 antibodies |
| 02/28/2008 | US20080050369 Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cells |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | DE19955576B4 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 02/28/2008 | CA2661558A1 Biomarkers for alzheimer's disease progression |
| 02/28/2008 | CA2661422A1 Methods and compositions for treating cancer |
| 02/28/2008 | CA2661054A1 Prophylactic and/or therapeutic agents for peripheral neuropathy |
| 02/28/2008 | CA2658835A1 Use of pkc inhibitors in ocular diseases |
| 02/27/2008 | EP1892250A2 CYR61 compositions and methods |
| 02/27/2008 | EP1891974A1 Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 02/27/2008 | EP1891973A1 Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 02/27/2008 | EP1891972A1 Agent for promoting hepatic cell replication and agent for improving insulin resistance |
| 02/27/2008 | EP1891971A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 02/27/2008 | EP1891970A1 Beta glucan-based vaccines free of mannoprotein |
| 02/27/2008 | EP1891969A2 Novel anti-allergic agents |
| 02/27/2008 | EP1891963A1 Use of antagonists of PPY receptors for treating visceral pain or visceral hypersensitivity |
| 02/27/2008 | EP1891954A2 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
| 02/27/2008 | EP1891951A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891950A1 Viral polymerase inhibitors |
| 02/27/2008 | EP1891948A1 Treatment of neurological and neuropsychological disorders |
| 02/27/2008 | EP1891209A1 Means and methods for generating a t cell against an antigen of interest. |
| 02/27/2008 | EP1891089A2 Hcv protease inhibitors in combination with food |
| 02/27/2008 | EP1891082A1 Novel inhibitors of pyruvate kinase as therapeutic agents for cancer |
| 02/27/2008 | EP1890767A2 Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| 02/27/2008 | EP1890729A2 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors |
| 02/27/2008 | EP1890728A1 Combination of hmg-coa reductase inhibitors amd mtor inhibitors |
| 02/27/2008 | EP1890727A1 Method and composition for treating osteoarthritis |
| 02/27/2008 | EP1890699A1 Indacterol derivatives and phosphodiesterase inhibitors for the treatment of airway diseases |
| 02/27/2008 | EP1663273B1 Powdery composition for use as a laxative |
| 02/27/2008 | EP1509251B1 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/27/2008 | EP1501452A4 Injectable chondrocyte implant |
| 02/27/2008 | EP1476193B1 A weight management system for obese animals |
| 02/27/2008 | EP1471143B1 Method and kit of judging the onset of rheumatoid arthritis |
| 02/27/2008 | EP1399423B9 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 02/27/2008 | EP1337263B1 A composition of rose hip and fish oil for alleviating joint pain and stiffness |
| 02/27/2008 | EP1334731B1 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist |
| 02/27/2008 | EP1282700B1 Neuronal serine-threonine protein kinase |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/27/2008 | EP1039906B1 metal complexes with antibacterian and fungicidal effects |
| 02/27/2008 | CN101132787A Adjunctive therapy for depression |
| 02/27/2008 | CN101132762A Production process for NSAID-containing lozenges, their compositions, their medicinal use |
| 02/27/2008 | CN101132698A Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 02/27/2008 | CN101132693A Compositions and methods for the management of hyperproliferative dermatological conditions |
| 02/27/2008 | CN101130084A Compound medicine for depressurization |
| 02/27/2008 | CN101130083A Ophthalmic composition, producing method and use of the same |
| 02/27/2008 | CN101130082A Novel photosensitive agent with function of carrying oxygen |